STAT November 7, 2025
O. Rose Broderick

Happy Friday! I hope you’re having a better day than the 531 patients in Maine and New Hampshire who mistakenly received letters confirming their death.

We’ve also got some juicy details regarding Thursday’s big GLP-1 announcement. Let’s get to it.

What to know about Trump’s weight loss drug deals

The Trump administration wants to make it easier for Americans to afford popular anti-obesity drugs made by Novo Nordisk and Eli Lilly, announcing Thursday a deal to offer more coverage for Medicare and Medicaid beneficiaries and lower prices across the board.

The most popular drugs, Wegovy and Zepbound, carry list prices of around $1,000 a month, and are available directly from the drugmakers without insurance for about $500.

The agreements...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Healthcare System, Public Health / COVID
Charted: Where measles is surging (again)
Flu Season Is a Stress Test. Our Healthcare System Keeps Failing.
Remembering A Global Health Hero
AAP Releases 2026 Child Vax Schedule, No Longer Endorses CDC's Version
Opinion: Our podcast ‘Why Should I Trust You?’ connects MAHA and public health. Here’s what we’ve learned

Share Article